These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37307132)

  • 1. Interleukin-6 (IL-6) as a Predictor of Clinical Outcomes in Patients with COVID-19.
    Mahmood SBZ; Majid H; Arshad A; Zaib-Un-Nisa ; Niazali N; Kazi K; Aslam A; Ahmed S; Jamil B; Jafri L
    Clin Lab; 2023 Jun; 69(6):. PubMed ID: 37307132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Immune-inflammatory markers & clinical characteristics for outcomes in hospitalized SARS-CoV-2 infected patients of Pakistan: a retrospective analysis'.
    Khalid A; Aqeel RF; Nawaz A; Ahmad J; Fatima ST; Shahid S; Rao AA; Aktas G; Ijaz S; Shehryar M
    Hematology; 2023 Dec; 28(1):2199629. PubMed ID: 37408482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basic Predictive Risk Factors for Cytokine Storms in COVID-19 Patients.
    Shcherbak SG; Anisenkova AY; Mosenko SV; Glotov OS; Chernov AN; Apalko SV; Urazov SP; Garbuzov EY; Khobotnikov DN; Klitsenko OA; Minina EM; Asaulenko ZP
    Front Immunol; 2021; 12():745515. PubMed ID: 34858403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretory Phospholipase A2 and Interleukin-6 Levels as Predictive Markers of the Severity and Outcome of Patients with COVID-19 Infections.
    Urazov S; Chernov A; Popov O; Klenkova N; Sushentseva N; Polkovnikova I; Apalko S; Kislyuk K; Pavlovich D; Ivanov A; Shcherbak S
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-6-based mortality risk model for hospitalized patients with COVID-19.
    Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
    J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory Response in COVID-19 Depending on the Severity of the Disease and the Vaccination Status.
    Trofin F; Nastase EV; Roșu MF; Bădescu AC; Buzilă ER; Miftode EG; Manciuc DC; Dorneanu OS
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil to lymphocytic ratio and other inflammatory markers as adverse outcome predictor in hospitalized COVID-19 patients.
    Abdelhady SA; Rageh F; Ahmed SS; Al-Touny SA; Riad E; Elhoseeny MM; Khalifa AA; Salim A; Farghly MI; Elgamal R
    Egypt J Immunol; 2022 Apr; 29(2):57-67. PubMed ID: 35436055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum interleukin-6 and lactate dehydrogenase levels among nonsurvival severe COVID-19 patients when compared to survival ones.
    Haroun RA; Osman WH; Amin RE; Eessa AM; Saad S
    Int Immunopharmacol; 2023 Sep; 122():110626. PubMed ID: 37459785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers and outcomes in hospitalised patients with COVID-19: a prospective registry.
    Khedar RS; Gupta R; Sharma K; Mittal K; Ambaliya HC; Gupta JB; Singh S; Sharma S; Singh Y; Mathur A
    BMJ Open; 2022 Dec; 12(12):e067430. PubMed ID: 36521904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality in Patients of COVID-19 Infection: Biochemical Markers and its Cut-off Values for Predicting Outcome.
    Yousaf MN; Sarwar S; Tarique S; Ahmed M; Tahir H
    J Coll Physicians Surg Pak; 2022 Jan; 32(1):37-41. PubMed ID: 34983145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the Impact of Inflammatory Markers and CT Severity Score on Disease Severity of COVID-19 Patients Admitted to ICU at a Tertiary Hospital.
    Kurri N; Tyagi B; Singhal E; Gupta N; Agarwal AK; Gupta V; Rai G; Bindra MS
    J Assoc Physicians India; 2021 Jun; 69(6):11-12. PubMed ID: 34472783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum biomarker panel for disease severity and prognosis in patients with COVID-19.
    Li J; Tang M; Liu D; Xie Z; Wang F; Yang Y
    J Clin Lab Anal; 2023 Jan; 37(2):e24831. PubMed ID: 36604799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of Association of Infection-related Biomarkers and Inflammatory Cytokines with the Severity of Coronavirus Disease 2019: A Prospective Observational Study.
    Injarapu RK; Tamboli A; Shah L; Phalgune D
    J Assoc Physicians India; 2024 Aug; 72(8):44-47. PubMed ID: 39163062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of altered level of blood-based biomarkers in prognosis of COVID-19 patients.
    Shrestha MR; Basnet A; Tamang B; Khadka S; Maharjan R; Maharjan R; Chand AB; Thapa S; Rai SK
    PLoS One; 2023; 18(8):e0287117. PubMed ID: 37540679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The predictive and prognostic role of hematologic and biochemical parameters in the emergency department among coronavirus disease 2019 patients.
    Huang CY; Tsai HW; Liu CY; Liu TH; Huang HL; Chang CC; Chen WC; Sun JT
    Chin J Physiol; 2021; 64(6):306-311. PubMed ID: 34975124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inflammatory biomarkers profile of hospitalized patients with COVID-19 and its association with patient's outcome: A single centered study.
    Hachim IY; Hachim MY; Hannawi H; Naeem KB; Salah A; Hannawi S
    PLoS One; 2021; 16(12):e0260537. PubMed ID: 34855832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical laboratory characteristics in patients with suspected COVID-19: One single-institution experience.
    Fei F; Smith JA; Cao L
    J Med Virol; 2021 Mar; 93(3):1665-1671. PubMed ID: 32946118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulatory Cytokine Levels as a Predictor of Disease Severity in COVID-19: A Study from Western India.
    Bhandari S; Rankawat G; Mathur S; Kumar A; Sahlot R; Jain A
    J Assoc Physicians India; 2022 May; 70(5):11-12. PubMed ID: 35598128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil-to-lymphocyte ratio, a critical predictor for assessment of disease severity in patients with COVID-19.
    Liu L; Zheng Y; Cai L; Wu W; Tang S; Ding Y; Liu W; Kou G; Xiong Z; Wang S; Zheng S
    Int J Lab Hematol; 2021 Apr; 43(2):329-335. PubMed ID: 33099889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective Cohort Observational Study to compare the Effect of Mycobacterium w along with Standard of Care vs Standard of Care alone in critically ill COVID-19 Patients.
    Dixit S; Zirpe K; Suryawanshi P; Borawake K; Prasad S; Ambapkar S; Ambapkar S; Joshi A; Joshi M
    J Assoc Physicians India; 2022 Jul; 70(7):11-12. PubMed ID: 35833395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.